31.08.2013 Views

towards improved death receptor targeted therapy for ... - TI Pharma

towards improved death receptor targeted therapy for ... - TI Pharma

towards improved death receptor targeted therapy for ... - TI Pharma

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

p38 and JNK induction by TRAIL<br />

rabbit‐IRDye (800CW;926‐32211 and 680;#926‐32221) were used. Protein expression was<br />

visualized with the Odyssey Infrared Imager (Westburg, Leusden, the Netherlands), at a 84<br />

µm resolution, 0 mm offset and with high quality [17].<br />

RNA interference<br />

H460 cells were plated at a density of 7.5 x10 4<br />

cells in 6‐well tissue culture plates and<br />

allowed to attach overnight. The next day, cells were incubated with serum‐free medium<br />

and transfected with 100 nM SignalSilence® p38 MAPK siRNA I (#6564), 100 nM<br />

SignalSilence® SAPK/JNK siRNA I (#6232), SignalSilence® Control siRNA (Fluorescein<br />

Conjugate) (#6201) (all from Cell Signaling Technology Inc), 20 pmol Mcl‐1 siRNA<br />

(Dharmacon, M‐004501‐08) or scrambled siRNA (Invitrogen) using Lipofectamine 2000<br />

(Invitrogen) according to the manufacturer’s protocol. Cells were then incubated <strong>for</strong> a<br />

minimum of 24 h be<strong>for</strong>e assaying <strong>for</strong> expression.<br />

For short hairpin (sh)RNA mediated silencing pSUPER.retro plasmid was used similarly as<br />

described previously [18]. Targeted shRNA sequences were inserted into the BglII and<br />

HindIII sites of the pSUPER.retro vector. All cloned shRNA sequences were verified by DNA<br />

sequencing. Retroviruses were packaged and introduced into cells as described previously<br />

[19]. H460 cells were retrovirally infected with control pSUPER.retro or pSUPER.retro‐<br />

shRIP1 (RIP1‐targeting sequence #1, 5'‐ GAGCAGCAGTTGATAATGT‐3'; RIP1‐targeting<br />

sequence #2 5'‐ TACCACTAGTCTGACGGATAA‐3') <strong>for</strong> 24 h. Infected cells were selected with<br />

2 µg/ml puromycin.<br />

Quantitative RT‐PCR<br />

Total RNA was extracted using the QiaAmp RNA mini‐Kit (Qiagen, San Diego, CA), and<br />

yields and purity were checked at 260‐280 nm with NanoDrop®‐1000‐Detector<br />

(NanoDrop‐Technologies, Wilmington, NC). RNA (500 ng) was reverse transcribed using<br />

the DyNAmo cDNA Synthesis Kit (Thermo Scientific, Vantaa, Finland), according to the<br />

manufacturers’ instruction. Primers and probes to specifically amplify Mcl‐1 and Bcl‐2<br />

were obtained from Applied Biosystems Assay‐on‐Demand Gene expression products<br />

(Hs01050896_m1, and Hs00608023_m1). The real‐time quantitative PCR was per<strong>for</strong>med in<br />

a 25 μl reaction volume containing TaqMan Universal master mix (Applied Biosystems,<br />

Forster City, CA). All reactions were per<strong>for</strong>med in triplicate using the ABI PRISM 7500<br />

sequence detection system instrument (Applied Biosystems). Samples were amplified<br />

using the following thermal profile: 50 °C <strong>for</strong> 2 min, 95 °C <strong>for</strong> 10 min, 40 cycles of<br />

denaturation at 95 °C <strong>for</strong> 15 sec followed by annealing and extension at 60 °C <strong>for</strong> 1 min.<br />

Amplifications were normalized to β‐actin, whose values were the closest to the geometric<br />

mean values observed <strong>for</strong> three housekeeping genes in preliminary analysis. Preliminary<br />

experiments were carried out with dilutions of cDNA obtained from Quantitative PCR<br />

Human Reference Total RNA (Stratagene, La Jolla, CA) to demonstrate that the efficiencies<br />

‐ 43 ‐

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!